SRNE at $1.90 -- Target Price Issued at $20! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SRNE at $1.90 -- Target Price Issued at $20!

SRNE 0.00780

+2.6%

Oct 31 9:30 AM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: albertaft	7/16/2017 7:35:19 AM
	of 4

Like I previously mentioned - Sorrento has partnership with the Chinese that most people aren't aware of. This could be the reason for the $20 target. First - Sorrento completed Phase III trials in China. Second - 60 days ago, Sorrento and China finished the completion of 25,000 sq ft Manufacturing Plant. Third - China company buys 3.8 million shares of Sorrento SRNE 60 days ago: fintel.io Fourth - China gives Sorrento 10 mill: fiercepharma.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next